AGP Picks
View all

Search results

Here's what we found for you. Looking for something more specific?

Nov. 12, 2026 Article

Massachusetts Woman’s Family Awarded $3.3 Million Against Johnson & Johnson in Mesothelioma Case

DALLAS--(BUSINESS WIRE)--Nov 11, 2026-- National plaintiffs trial firm Dean Omar Branham Shirley, LLP, (DOBS) has secured a verdict in the amount of $1,914,990 accompanied by court ordered interest of $1,410,541 for a sum total of $3,325,631...

Nov. 10, 2026 Press Release

US Navy Veterans Lung Cancer & Mesothelioma Advocate Demands the US Congress Assist Navy Veterans Who Developed Lung Cancer or Asbestosis Because of Asbestos Exposure-The Navy Never Warned the Sailors About the Risks

WASHINGTON , DC, UNITED STATES, November 10, 2026 /⁨EINPresswire.com⁩/ -- The US Navy Veterans Lung Cancer & Mesothelioma Advocate is calling on the United States Congress to address what it considers a long-overlooked issue affecting generations...

Nov. 10, 2026 Article

What Compensation Can a Veteran With Mesothelioma Receive?

A mesothelioma diagnosis can place financial pressure on veterans and their families. Treatment may involve specialist care, travel, and time away from work. Veterans exposed to asbestos during military service may qualify for compensation through...

Nov. 10, 2026 Article

Ask Nurse Liz: What Should I Do After a Mesothelioma Diagnosis?

Getting a mesothelioma diagnosis can be overwhelming. You may still be processing the news while trying to understand your test results, find an experienced doctor, and make important treatment decisions. Whether you were just diagnosed or have...

Nov. 10, 2026 Article

Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027

Microscopic view of mesothelioma cancer cells. [Adobe Stock] Patients with mesothelioma, a cancer of the lining of the chest or abdomen, have few treatment options after their disease progresses. Insilico Medicine, a Cambridge, Mass.-based drug...

Nov. 9, 2026 Press Release

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Following FDA orphan drug designation in 2025, the European decision marks a further milestone as Oncovita prepares to initiate clinical development in late 2027 The European Commission granted orphan designation on October 19, 2026, following a...

Nov. 3, 2026 Article

Mesothelioma Hope Launches New Research Initiative, Identifies States With Least Access to Specialist Care

New data analysis reveals Maine, Alaska, and Wyoming as the most underserved states for mesothelioma treatment, despite not having the highest raw death counts, highlighting geographic disparities in access to specialized care. CHESTNUT HILL, MA /...

3 hours ago Article

Couple’s warning after dream renovation turns into costly nightmare

Exclusive: When Ethan and Kai Anderson first set eyes on the property that would become their first home, it was love at first sight. “It looked like an eyesore when we bought it, it was a very big fixer-upper, but both my husband and I saw every...

Nov. 6, 2026 Article

Veterans Day 2026: Supporting U.S. Veterans With Mesothelioma and All Who Served

Taking place on November 11 each year, Veterans Day honors those who served in all branches of the United States Armed Forces. U.S. veterans risked their lives to defend our nation’s freedoms, and many are currently facing serious health problems...

Nov. 3, 2026 Press Release

Mesothelioma Victims Center Appeals to the Family of a Plumber or Skilled Trade Worker with Lung Cancer or Mesothelioma Nationwide to Call them for Direct Access to the Nation's Best Lawyers-Get Top Compensation Results

WASHINGTON , DC, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- According to the Mesothelioma Victims Center, “If your husband or dad is a former plumber or skilled trades worker anywhere in the USA and has recently been diagnosed with...

Nov. 6, 2026 Article

$5 Million Awarded in Georgia Mesothelioma Lawsuit

A Georgia jury awarded $5 million to Greg Lassiter, who was diagnosed with peritoneal mesothelioma after years of working on motorcycles. The October 2026 verdict followed an extended legal battle over asbestos exposure from motorcycle brake...

Nov. 5, 2026 Article

Family appeal for information after mother’s mesothelioma death

The family of a Liverpool woman who died from asbestos-related cancer believe her illness may have been caused by washing her husband’s work clothes and are appealing for former colleagues to come forward. Angela Barry, 82, died from mesothelioma...

Nov. 5, 2026 Article

Immunotherapy Helps Pleural Mesothelioma Patients Survive Longer Without Surgery in New Study

For people with pleural mesothelioma whose cancer can’t be removed with surgery, immunotherapy may offer a way to live longer. An updated real-world study examined the long-term results of nivolumab (Opdivo®) plus ipilimumab (Yervoy®), two...

Oct. 31, 2026 Article

Johnson & Johnson Successfully Secures Defense Verdict In a Wrongful Death Mesothelioma Trial in Ohio

Court of Common Pleas, Cuyahoga County, Ohio Plaintiff Marwin L. Smith, executor of the estate of Audrey L. Smith, filed an asbestos lawsuit alleging that the decedent was exposed to asbestos through her personal use of Johnson’s Baby Powder and...

Oct. 30, 2026 Article

ISM6331 Shows Promising Early Mesothelioma Results at ESMO 2026

Insilico Medicine’s experimental mesothelioma drug, ISM6331, has reached another important milestone. Early clinical trial results show signs that it may help shrink tumors in patients who’ve already received other treatments. On October 25, 2026,...

Oct. 30, 2026 Article

Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen. Most patients are diagnosed with mesothelioma late, resulting in a...

Oct. 29, 2026 Article

Roche launches test for differential diagnosis of mesothelioma globally

Roche has announced the global launch of the VENTANA BAP1 (SP527) test, an automated, ready-to-use immunohistochemistry (IHC) assay to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies,...

Oct. 28, 2026 Article

Roche Launches New Test To Help Diagnose Mesothelioma

Roche (RHHBY) has launched a new diagnostic test designed to help distinguish malignant mesothelioma, a rare cancer affecting the lining of internal organs, from other cancers and benign tissue growths. Mesothelioma most commonly affects the...

Oct. 28, 2026 Article

Machine Learning Pinpoints 12 Candidate Biomarkers for Mesothelioma

Researchers have combined gene co-expression network analysis with machine learning to nominate a panel of twelve candidate biomarkers for malignant pleural mesothelioma, an aggressive cancer of the lining of the lung that is primarily linked to...

Oct. 20, 2026 Press Release

Mesothelioma Compensation Center Urges Former Chemical Plant or Oil Refinery Workers with Lung Cancer or Mesothelioma-To Call Them About Getting Better Compensated Via Top Lawyers to Get the Job Done

WASHINGTON , DC, UNITED STATES, October 20, 2026 /⁨EINPresswire.com⁩/ -- The Mesothelioma Compensation Center is urging the family of a former chemical plant worker who has recently been diagnosed with lung cancer or mesothelioma to call...

Sign up for:

Today in Law

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Law

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.